دورية أكاديمية

376 Overcoming tumor heterogeneity – Clinical trial assays to prospectively assign patients customized multiplexed TCR-T cell therapy in Phase 1

التفاصيل البيبلوغرافية
العنوان: 376 Overcoming tumor heterogeneity – Clinical trial assays to prospectively assign patients customized multiplexed TCR-T cell therapy in Phase 1
المؤلفون: Yun Wang, Henry Tsai, Sam Harris, Andrew Nguyen, Ribhu Nayar, Sonal Jangalwe, Alexander Cristofaro, Nancy Nabilsi, Gavin MacBeath, Debora Barton, Ariane Lozac’hmeur, Qidi Yang, Teagan Parsons, Shazad A Khokhar, Sveta Padmanabhan, Antoine J Boudot, Livio Dukaj, Cagan Gurer, Jeffrey Coleman, Adam Hsiung, Chunghun Chang, Shehla Arain, Jessica Rathbun, Ruey Pham, Shardul Soni, Tyler Danek, Katie Marshall, Amanda Jensen, Chris Riley, Erica Buonomo, Shrikanta Chattopadhyay
المصدر: Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
بيانات النشر: BMJ Publishing Group, 2023.
سنة النشر: 2023
المجموعة: LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens
مصطلحات موضوعية: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
نوع الوثيقة: article
وصف الملف: electronic resource
اللغة: English
تدمد: 2051-1426
Relation: https://doaj.org/toc/2051-1426
DOI: 10.1136/jitc-2023-SITC2023.0376
URL الوصول: https://doaj.org/article/6601126fc1e2495287a86465b885a3f9
رقم الأكسشن: edsdoj.6601126fc1e2495287a86465b885a3f9
قاعدة البيانات: Directory of Open Access Journals
الوصف
تدمد:20511426
DOI:10.1136/jitc-2023-SITC2023.0376